ARCHIVES

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Jordan To Join MD Anderson Cancer Center

July 25, 2014

No Site Visit For Georgetown Lombardi as Federal Government Shuts Down

October 4, 2013

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

May 31, 2013

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

March 21, 1997

Public Meeting On Ionizing Radiation Set

January 11, 1980

Study Confirms Cancer Risk Increase Due To Combined HRT

January 31, 2003